STENGONE CARMINE N. (CEO and President) sold 36.7% of their position (10K shares) of CONTINEUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $160.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Class A Common Stock
Shares
+7.50K
Price / share
$1.01
Trade value
$7.58K
% of position
Class A Common Stock
Shares
+2.50K
Price / share
$1.26
Trade value
$3.15K
% of position
Class A Common Stock
Shares
−10K
Price / share
$16.01
Trade value
$160.08K
% of position
Net shares
+0.00
Net value
-$149.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/30/2026 | M · Option Exercise | +7.50K | $1.01 | $7.58K | 43.6% | 17.22K | 24.72K |
| Class A Common Stock Direct | 6/30/2026 | M · Option Exercise | +2.50K | $1.26 | $3.15K | 10.1% | 24.72K | 27.22K |
| Class A Common Stock Direct | 6/30/2026 | S · Sale | −10K | $16.01 | $160.08K | 36.7% | 27.22K | 17.22K |
| Total | +0.00 | -$149.35K | ||||||
Stock Option (right to buy)
Class A Common Stock
7.50K shares
Shares
−7.50K
Strike price
1.01
Held after
281.93K
Exercisable
—
Stock Option (right to buy)
Class A Common Stock
2.50K shares
Shares
−2.50K
Strike price
1.26
Held after
118.42K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Class A Common Stock7.50K shares | 6/30/2026 | M · Option Exercise | −7.50K | 1.01 | — | 281.93K |
| Stock Option (right to buy) Direct | Class A Common Stock2.50K shares | 6/30/2026 | M · Option Exercise | −2.50K | 1.26 | — | 118.42K |